ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 161 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2015. The put-call ratio across all filers is 1.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $4,000 | -20.0% | 80 | -2.4% | 0.00% | -33.3% |
| Q2 2017 | $5,000 | -16.7% | 82 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $6,000 | +100.0% | 82 | +127.8% | 0.00% | +200.0% |
| Q4 2016 | $3,000 | -50.0% | 36 | -59.1% | 0.00% | -75.0% |
| Q3 2016 | $6,000 | +100.0% | 88 | +54.4% | 0.00% | +100.0% |
| Q2 2016 | $3,000 | -25.0% | 57 | 0.0% | 0.00% | -33.3% |
| Q1 2016 | $4,000 | -42.9% | 57 | 0.0% | 0.00% | -40.0% |
| Q4 2015 | $7,000 | +16.7% | 57 | 0.0% | 0.01% | 0.0% |
| Q3 2015 | $6,000 | – | 57 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 519,119 | $40,605,000 | 3.00% |
| First Light Asset Management, LLC | 236,958 | $18,535,000 | 2.16% |
| SECTOR GAMMA AS | 108,734 | $8,505,000 | 1.76% |
| Rock Springs Capital Management LP | 646,841 | $50,596,000 | 1.39% |
| Atika Capital Management LLC | 79,000 | $6,180,000 | 0.80% |
| Capital Impact Advisors, LLC | 30,582 | $2,392,000 | 0.80% |
| FEDERATED HERMES, INC. | 4,080,359 | $319,166,000 | 0.79% |
| Rhenman & Partners Asset Management AB | 61,500 | $4,811,000 | 0.52% |
| Ikarian Capital, LLC | 73,500 | $5,749,000 | 0.46% |
| Capital International, Inc./CA/ | 477,858 | $37,378,000 | 0.46% |